Pakistan Blood and Marrow Transplant (PBMT) Group

Quick facts

Phase 2 pipeline

• ADDITION OF THALIDOMIDE AND HYDROXYUREA · Oncology / Hematology
  Thalidomide and hydroxyurea work synergistically to inhibit angiogenesis, promote apoptosis of abnormal cells, and enhance fetal hemoglobin production while reducing sickling and hemolysis.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Pakistan Blood and Marrow Transplant (PBMT) Group portfolio CI brief
• Pakistan Blood and Marrow Transplant (PBMT) Group pipeline updates RSS

Related

• Sector hub: All tracked pharma companies